Use of ivermectin in patients with covid-19: a narrative review
Descripción del Articulo
Introduction. Towards the end of the last month of 2019, a new highly contagious coronavirus was identified in China causing the start of a new pandemic. Millions of infected people and thousands of deaths are the result of SARS-CoV-2 infection; different therapeutic strategies have been proposed fo...
| Autores: | , , , |
|---|---|
| Formato: | artículo |
| Fecha de Publicación: | 2021 |
| Institución: | Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo |
| Repositorio: | Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo |
| Lenguaje: | español |
| OAI Identifier: | oai:cmhnaaa_ojs_cmhnaaa.cmhnaaa.org.pe:article/780 |
| Enlace del recurso: | https://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/780 |
| Nivel de acceso: | acceso abierto |
| Materia: | COVID-19 SARS-CoV-2 ivermectina ivermectin |
| id |
REVCMH_c5bc91ef4d030fbc48bd9aad4aa3960e |
|---|---|
| oai_identifier_str |
oai:cmhnaaa_ojs_cmhnaaa.cmhnaaa.org.pe:article/780 |
| network_acronym_str |
REVCMH |
| network_name_str |
Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo |
| repository_id_str |
|
| spelling |
Use of ivermectin in patients with covid-19: a narrative reviewUso de ivermectina en pacientes con la COVID-19: Una revisión narrativaCastañeda-Marín, ElioGonzalez-Gonzalez, AlexanderGrau-Bocanegra, RicardoCaballero-Alvarado, JoséCOVID-19SARS-CoV-2ivermectinaCOVID-19SARS-CoV-2ivermectinIntroduction. Towards the end of the last month of 2019, a new highly contagious coronavirus was identified in China causing the start of a new pandemic. Millions of infected people and thousands of deaths are the result of SARS-CoV-2 infection; different therapeutic strategies have been proposed for its treatment, one of them has been ivermectin, causing discrepancies in the medical community regarding its use. We set out to review the available scientific evidence on the use of ivermectin in the context of IDVC-19 in humans. A literature search was conducted on the following databases: Pub Med, Web of Science, Cochrane, Clinical Trials, and ISRCCTN using search expressions that include the following terms: ivermectin, antiviral, virus, covid-19 and/or SARS-CoV-2. There is no scientific evidence to support the use of ivermectin as a treatment and/or prophylaxis for SARS-CoV-2 infection.Introducción. Hacia finales del último mes del 2019, se identificó un nuevo coronavirus altamente contagioso en China provocando el inicio de una nueva pandemia. Millones de infectados y miles de muertes es el resultado de la infección por el SARS-CoV-2; diferentes estrategias terapéuticas se han propuesto para su tratamiento, una de ellas ha sido la ivermectina, provocando discrepancias en la comunidad médica en relación a su uso. Nos propusimos revisar la evidencia científica disponible sobre el uso de la ivermectina en el contexto de la COVID-19 en humanos. Se realizó una búsqueda de bibliografía en las siguientes bases de datos: Pub Med, Web of Science, Cochrane, Clinical Trials e ISRCCTN usando expresiones de búsqueda que incluyan los siguientes términos: ivermectina, antiviral, virus, covid-19 y/o SARS-CoV-2. No hay evidencia científica que respalde el uso de ivermectina como tratamiento y/o profilaxis para la infección por SARS COV-2.Cuerpo Médico del Hospital Nacional Almanzor Aguinaga Asenjo2021-02-19info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/78010.35434/rcmhnaaa.2020.134.780Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo; Vol. 13 No. 4 (2020): Rev. Cuerpo Med. HNAAA; 440 - 445Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo; Vol. 13 Núm. 4 (2020): Rev. Cuerpo Med. HNAAA; 440 - 4452227-47312225-5109reponame:Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjoinstname:Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjoinstacron:HNAAAspahttps://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/780/386Derechos de autor 2020 Revista del Cuerpo Médico del HNAAAinfo:eu-repo/semantics/openAccessoai:cmhnaaa_ojs_cmhnaaa.cmhnaaa.org.pe:article/7802021-06-14T05:32:30Z |
| dc.title.none.fl_str_mv |
Use of ivermectin in patients with covid-19: a narrative review Uso de ivermectina en pacientes con la COVID-19: Una revisión narrativa |
| title |
Use of ivermectin in patients with covid-19: a narrative review |
| spellingShingle |
Use of ivermectin in patients with covid-19: a narrative review Castañeda-Marín, Elio COVID-19 SARS-CoV-2 ivermectina COVID-19 SARS-CoV-2 ivermectin |
| title_short |
Use of ivermectin in patients with covid-19: a narrative review |
| title_full |
Use of ivermectin in patients with covid-19: a narrative review |
| title_fullStr |
Use of ivermectin in patients with covid-19: a narrative review |
| title_full_unstemmed |
Use of ivermectin in patients with covid-19: a narrative review |
| title_sort |
Use of ivermectin in patients with covid-19: a narrative review |
| dc.creator.none.fl_str_mv |
Castañeda-Marín, Elio Gonzalez-Gonzalez, Alexander Grau-Bocanegra, Ricardo Caballero-Alvarado, José |
| author |
Castañeda-Marín, Elio |
| author_facet |
Castañeda-Marín, Elio Gonzalez-Gonzalez, Alexander Grau-Bocanegra, Ricardo Caballero-Alvarado, José |
| author_role |
author |
| author2 |
Gonzalez-Gonzalez, Alexander Grau-Bocanegra, Ricardo Caballero-Alvarado, José |
| author2_role |
author author author |
| dc.subject.none.fl_str_mv |
COVID-19 SARS-CoV-2 ivermectina COVID-19 SARS-CoV-2 ivermectin |
| topic |
COVID-19 SARS-CoV-2 ivermectina COVID-19 SARS-CoV-2 ivermectin |
| description |
Introduction. Towards the end of the last month of 2019, a new highly contagious coronavirus was identified in China causing the start of a new pandemic. Millions of infected people and thousands of deaths are the result of SARS-CoV-2 infection; different therapeutic strategies have been proposed for its treatment, one of them has been ivermectin, causing discrepancies in the medical community regarding its use. We set out to review the available scientific evidence on the use of ivermectin in the context of IDVC-19 in humans. A literature search was conducted on the following databases: Pub Med, Web of Science, Cochrane, Clinical Trials, and ISRCCTN using search expressions that include the following terms: ivermectin, antiviral, virus, covid-19 and/or SARS-CoV-2. There is no scientific evidence to support the use of ivermectin as a treatment and/or prophylaxis for SARS-CoV-2 infection. |
| publishDate |
2021 |
| dc.date.none.fl_str_mv |
2021-02-19 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
https://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/780 10.35434/rcmhnaaa.2020.134.780 |
| url |
https://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/780 |
| identifier_str_mv |
10.35434/rcmhnaaa.2020.134.780 |
| dc.language.none.fl_str_mv |
spa |
| language |
spa |
| dc.relation.none.fl_str_mv |
https://cmhnaaa.org.pe/ojs/index.php/rcmhnaaa/article/view/780/386 |
| dc.rights.none.fl_str_mv |
Derechos de autor 2020 Revista del Cuerpo Médico del HNAAA info:eu-repo/semantics/openAccess |
| rights_invalid_str_mv |
Derechos de autor 2020 Revista del Cuerpo Médico del HNAAA |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
Cuerpo Médico del Hospital Nacional Almanzor Aguinaga Asenjo |
| publisher.none.fl_str_mv |
Cuerpo Médico del Hospital Nacional Almanzor Aguinaga Asenjo |
| dc.source.none.fl_str_mv |
Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo; Vol. 13 No. 4 (2020): Rev. Cuerpo Med. HNAAA; 440 - 445 Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo; Vol. 13 Núm. 4 (2020): Rev. Cuerpo Med. HNAAA; 440 - 445 2227-4731 2225-5109 reponame:Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo instname:Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo instacron:HNAAA |
| instname_str |
Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo |
| instacron_str |
HNAAA |
| institution |
HNAAA |
| reponame_str |
Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo |
| collection |
Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1846434815861063680 |
| score |
13.057984 |
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).
